However, our data demonstrate that both TLR2 and TLR4-dependent stimuli activate the MEK1/2-ERK1/2 pathway in CF macrophages, and that activation can be reduced with MEK1/2 inhibitor compounds. The gene discussed is TLR4; the disease is cystic fibrosis.